Neoadjuvant androgen deprivation therapy with or without Fc-enhanced non-fucosylated anti-CTLA-4 (BMS-986218) in high risk localized prostate cancer: a randomized phase 1 trial
高风险局限性前列腺癌的新辅助雄激素剥夺疗法联合或不联合 Fc 增强型非岩藻糖基化抗 CTLA-4 (BMS-986218)：一项随机 1 期试验
期刊:
影响因子:
doi:10.1101/2024.09.09.24313308
Casey R Ager, Aleksandar Obradovic, Patrick McCann, Matthew Chaimowitz, Alexander L E Wang, Neha Shaikh, Parin Shah, Samuel Pan, Caroline J Laplaca, Renu K Virk, Jessica C Hill, Collin Jugler, Grace DeFranco, Nilika Bhattacharya, Howard I Scher, Guarionex Joel DeCastro, Christopher B Anderson, James
